Revolutionary Insights & Engineering Excellence in Cardiac Healthcare
From Initial Concept to Market-Ready Device,
We Provide a Unified Path
Bringing a groundbreaking cardiovascular device to market requires more than just innovation—it demands a seamless journey from conceptualization to commercialization. Our expertise in cardiovascular device development, combined with our cutting-edge in vitro and ex vivo testing facilities, advanced computational modeling tools and prototyping technologies eliminate the fragmentation that slows progress. By providing a unified platform for device commercialization, we enable innovators to de-risk their designs, accelerate development timelines, and confidently navigate the regulatory process. We don’t just solve problems; we redefine what’s possible in cardiac healthcare in the most efficient and effective way.
Design & development projects
Analyzed Patients’ data
Secured patents
Pages of technical report
Cardiac device development consultation from ideation to commercial use in patients
Providing engineering and efficacy and efficiency assessment service to cardiovascular device manufacturers and pharmaceutical companies and clinical teams
Diganics specializes in developing innovative cardiovascular devices and diagnostic tools. A key focus of its activities is providing technical support to medical device companies and physicians in engineering, development, and validation of cardiovascular devices and speed up the commercialization process particularly transcatheter, surgical and mechanical heart valves.
Pioneering extensive analysis of heart valve replacement outcome
Unique arsenal for device development with unprecedentedly accurate prediction of
transcatheter and surgical heart valve outcomes
Design optimization
Advanced patient-specific computational tools to optimize the design based on real-life conditions.
Computational device-efficacy assessment
Advanced patient-specific computational tools to simulate the efficacy of device.
Advanced prototyping
Advanced methods, tools and frameworks to make the patient-specific 3-D prints.
In vitro device efficacy assessment
State-of-the-art patient-specific in vitro simulator to test the efficacy of the devices.
Detailed flow characterization
Advanced high-speed high-resolution 4-camera particle image velocimetry measurement.
Verification with clinical imaging
Advanced imaging systems and advanced clinical ultrasound machines for verification.
Ex vivo device efficacy assessment
Advanced methods, tools and frameworks to make the patient-specific 3-D prints.
In vitro disease assessment
State-of-the-art patient-specific in vitro simulator to test assess and classify the disease.
The FDA has recognized that patient-specific computational modeling applications are continually expanding and becoming a critical component of medical device development. These applications play an increasingly significant role in providing evidence of safety and performance in regulatory submissions. Diagnics’ computational algorithms and experimental setups support all requirements outlined by the FDA in its guidance document.
(Assessing the Credibility of Computational Modeling and Simulation in Medical Device Submissions November 17, 2023.)
Innovating for Patient Outcomes
The medical device commercialization process is complex and fragmented. Our expertise in cardiac device development, from ideation to commercialization, streamlines the path to market. Our work is driven by a singular purpose: to deliver life-saving solutions that improve patient outcomes.
Do you have an innovative cardiovascular device idea?
Our engineering team—specialized in the design, research, and development of cardiovascular devices—offers comprehensive, end-to-end support to companies, clinical teams, and individual innovators. From conceptualization to bedside application, we guide you through every stage of development and commercialization, transforming your vision into a tangible, life-saving solution.